How do I sue a drug company for a dangerous medication in Georgia?
A claim against a drug manufacturer in Georgia follows the same product-liability foundation as other defective-product cases, but prescription medications carry their own rules about warnings, causation, and the role of the prescribing physician. Understanding those features is key to seeing how such a case works.
The basis for a claim ¶
The strict-liability framework that O.C.G.A. § 51-1-11 applies to a defective product’s maker carries over to pharmaceuticals as well. A medication claim generally rests on one of a few theories: that the drug was defectively designed, that it was contaminated or improperly manufactured, or that the manufacturer failed to provide adequate warnings about its risks. Failure-to-warn claims are especially common in drug cases, because much of the dispute centers on what risks were disclosed and how.
The learned-intermediary rule shapes warning claims ¶
A distinctive feature of drug litigation is the learned-intermediary doctrine, which Georgia applies. Under it, a prescription-drug manufacturer’s duty to warn generally runs to the prescribing physician rather than directly to the patient, on the theory that it is the doctor, weighing whether the medication suits a given patient, who is the right recipient of the risk information. This affects how a warning claim is proven. An injured person typically must show that an adequate warning would have changed the prescribing physician’s decision, which means the physician’s testimony often becomes central to causation.
What a case generally requires ¶
Building a medication claim usually involves several connected elements:
- Identifying the specific defect or inadequate warning at issue.
- Showing the drug caused the injury, which can require medical and scientific proof.
- For warning claims, linking the inadequate warning to the prescribing decision through the physician.
Because causation in drug cases turns on complex medical evidence, these claims tend to depend heavily on records and expert analysis.
Deadlines and verification ¶
A drug case still has to be filed within the two years O.C.G.A. § 9-3-33 sets for personal-injury suits, and a separate doctrine of federal preemption can affect certain pharmaceutical claims depending on the drug and the theory involved. Because the specifics vary, the viability of a claim depends on the particular medication, injury, and facts rather than on any single rule.
The bottom line ¶
Suing a drug company in Georgia builds on the state’s product-liability law, with claims commonly framed around design, manufacturing, or inadequate warnings. The learned-intermediary doctrine shifts the warning duty toward the prescribing physician and makes the physician’s role central to causation, so these cases turn heavily on medical proof and the specific facts of the prescription and injury.
This article is for general educational and informational purposes only and is not legal advice. It does not create an attorney-client relationship, and Georgia law may change. For advice about a specific situation, consult a licensed Georgia personal injury attorney.